Navigation Links
3SBio Inc. Schedules 2007 Third Quarter Earnings Release On Tuesday, November 13, 2007
Date:10/31/2007

Earnings Conference Call to be held on November 14, 2007 at 5:00 a.m.

(Pacific) / 8:00 a.m. (Eastern) / 9:00 p.m. (Beijing/Hong Kong)

SHENYANG, China, Oct. 31 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release unaudited financial results for the third quarter ended September 30, 2007 after the US market closes on Tuesday, November 13, 2007.

The earnings release will be available on the investor relations page of its website at http://www.3sbio.com/en/News/ShowInfo_n12.aspx?ID=26.

Following the earnings announcement, 3SBio Inc. senior management will host a conference call at 5:00 a.m. (Pacific) / 8:00 a.m. (Eastern) / 9:00 p.m. (Beijing/Hong Kong) on Wednesday, November 14, 2007 to discuss its 2007 third quarter financial results and recent business activity. The conference call may be accessed by calling (US) +1 480 629 9562 / (UK) +44 (0)20 8515 2301 / (HK) +852 3009 5027. A telephone replay will be available shortly after the call until November 28, 2007 at (US) +1 303 590 3030/ (UK) +44 (0)20 7154 2833, Passcode: 3801272; and (HK) +852 2287 4304, Passcode: 101 110#.

A live webcast of the conference call and replay will be available on the investor relations page of 3SBio's website at http://www.3sbio.com/en/News/ShowInfo_nnn1.aspx?ID=26.

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at http://www.3sbio.com.

For more information, please contact:

Investors:

Clara Mak

CFO

3SBio Inc.

Phone: +86-24-2581-1820

Investor Relations (US):

Mahmoud Siddig

Taylor Rafferty

Phone: +1-212-889-4350

Investor Relations (HK):

Ruby Yim

Taylor Rafferty

Phone: +852-3196-3712

Media Contact:

John Dooley

Taylor Rafferty

Phone: +1-212-889-4350


'/>"/>
SOURCE 3SBio Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Visions: Broderick says Wisconsin should be in top third in venture capital
2. Third Wave files countersuit vs. Digene in patent case
3. Third Wave reports net loss of $18.9M for 2006
4. Stratagene to pay Third Wave $10.75M in patent case
5. Third Wave responds to Digene patent lawsuit
6. Third Wave seeks approval of Cystic Fibrosis test
7. Third Wave Technologies to raise $14.9M through private debt
8. Venture capital above $6B for third straight quarter
9. Third Wave reports $5.2M third quarter loss
10. Third Wave reports another loss, stronger sales
11. Napier joins board of Third Wave Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... , ... March 22, 2017...Council for Agricultural Science and Technology, Ames, Iowa. ... innovation in smart, sustainable ways. Humans depend on plants for food, feed, fiber, and ... This paper is the first in a series that connects science and technology to ...
(Date:3/22/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced Alexey ... present at the 5th Annual Cancer BioPartnering & ... to present to and meet with thought leaders ... companies as well as institutional investors. This event ...
(Date:3/20/2017)... Diego, CA (PRWEB) , ... ... ... (EDCs) are substances that interfere with the ability of endogenous hormones to ... or inhibiting ligand binding activity (antagonists), EDCs produce adverse reproductive, neurological, proliferative, ...
(Date:3/20/2017)... (PRWEB) , ... March 20, 2017 , ... ... expensive and laborious sample preparation methods in order to reduce the impact on ... outside of the area of elemental analysis. , This presentation will discuss ...
Breaking Biology Technology:
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
Breaking Biology News(10 mins):